|
|
|
|
|
|
Skip has spent more than twenty years advising companies on business strategy,
technology commercialization, R&D planning, and mergers and acquisitions in
the medical products industry. A pharmacist by training, Skip's practice
focuses on pharmaceuticals and biotechnology.
Prior to joining Health Advances, Skip helped found seven life sciences
companies as Vice President for Commercial Development at the Massachusetts
Biotechnology Research Institute (MBRI). Earlier in his career, Skip founded
and led the pharmaceutical consulting practice for Arthur D. Little, Inc.
He has also previously worked in manufacturing and product development for
AstraZeneca, and he contributed to the founding of t. Breeders, Inc., which
eventually became ViaCell, Inc. and was purchased by Perkin Elmer.
Leveraging his knowledge of the biopharma industry, Skip has developed a
practice advising not-for-profit disease organizations on their investments
and relationships with industry. He serves on the Board of Directors for the
Michael J. Fox Foundation for Parkinson's Research.
Skip graduated from the Massachusetts College of Pharmacy and earned his
MBA at the Amos Tuck School at Dartmouth College.
|
|
 |
|
|
|
|
